IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Condition(s):Retinopathy of Prematurity (ROP)Last Updated:June 7, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Retinopathy of Prematurity (ROP)Last Updated:June 7, 2017Completed
Condition(s):Diabetic RetinopathyLast Updated:May 7, 2020Completed
Condition(s):Retinopathy of PrematurityLast Updated:June 2, 2011Completed
Condition(s):Diabetic RetinopathyLast Updated:September 16, 2020Recruiting
Condition(s):Diabetic Retinopathy; Diabetic Macular Edema; NPDR – Non Proliferative Diabetic Retinopathy; PDR – Proliferative Diabetic RetinopathyLast Updated:March 30, 2021Recruiting
Condition(s):Diabetic RetinopathyLast Updated:April 8, 2021Recruiting
Condition(s):Diabetic RetinopathyLast Updated:May 22, 2020Completed
Condition(s):Diabetic RetinopathyLast Updated:March 4, 2021Not yet recruiting
Condition(s):Retinopathy of PrematurityLast Updated:June 26, 2014Completed
Condition(s):Diabetic Retinopathy; Diabetic Eye Problems; Diabetic Macular EdemaLast Updated:March 18, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.